| http://www.w3.org/ns/prov#value | - Acquisitions, Funding, Business, and Stock CTG reports Q4 results: revenue down 4 percent, EPS $0.08 vs. $0.22, not including a $0.07 expense associated with the October death of CEO James Boldt and a $0.06 write-down of the company???s investment in poor-selling medical fraud, waste, and abuse software.
|
